Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Nov;69(11):3287-3288.
doi: 10.4103/ijo.IJO_2406_21.

Commentary: Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study

Affiliations
Comment

Commentary: Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment - A quasi-randomized retrospective study

Ashish A Ahuja et al. Indian J Ophthalmol. 2021 Nov.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None

Comment on

References

    1. Wirkkala J, Bloigu R, Hautala NM. Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy. BMJ Open Ophthalmology. 2019;4:e000390. - PMC - PubMed
    1. Jorge DM, Tavares Neto JEDS, Poli-Neto OB, Scott IU, Jorge R. Intravitreal bevacizumab (IVB) versus IVB in combination with pars plana vitrectomy for vitreous hemorrhage secondary to proliferative diabetic retinopathy: A randomized clinical trial. Int J Retina Vitreous. 2021;7:35. - PMC - PubMed
    1. Chakraborty D, Maiti A, Kelkar A, Sengupta S, Roy S, Bolisetty M, et al. Outcomes of preoperative bevacizumab in diabetics with nonclearing vitreous hemorrhage without tractional detachment –A quasi-randomized retrospective study. Indian J Ophthalmol. 2021;69:3283–7. - PMC - PubMed
    1. Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology. 1989;96:1501–10. - PubMed
    1. García-Quintanilla L, Luaces-Rodríguez A, Gil-Martínez M, Mondelo-García C, Maroñas O, Mangas-Sanjuan V, et al. Pharmacokinetics of intravitreal anti-VEGF drugs in age-related macular degeneration. Pharmaceutics. 2019;11:365. - PMC - PubMed